Financial Performance - Operating revenue for the reporting period was CNY 1,163,613,610.31, representing a 15.81% increase year-on-year[8] - Net profit attributable to shareholders was a loss of CNY 7,788,728.58, a decrease of 302.00% compared to the same period last year[8] - The company reported a basic earnings per share of -CNY 0.0097, a decrease of 302.08% year-on-year[8] - The company's net loss for the period was CNY 11,127,377.01, reflecting a significant increase in operating costs[46] - The net profit for the third quarter was a loss of CNY 8,959,283.67, compared to a profit of CNY 3,748,128.29 in the same period last year, indicating a significant decline[48] - The total comprehensive income for the third quarter was a loss of CNY 11,769,917.85, contrasting with a gain of CNY 3,033,976.56 in the previous year[48] - The company's net profit for Q3 2020 was -64,423,446.71 CNY, a significant decline compared to a net profit of 11,246,366.82 CNY in Q3 2019, representing a year-over-year decrease of approximately 674%[55] - Operating revenue for the year-to-date period was 2,285,065,753.97 CNY, down from 2,428,168,419.40 CNY in the same period last year, indicating a decrease of about 5.9%[57] - The gross profit margin for the year-to-date period was approximately 6.6%, down from 9.3% in the previous year, reflecting increased costs and reduced sales efficiency[57] - The company reported a total comprehensive income of -63,020,466.66 CNY for Q3 2020, compared to 11,441,583.77 CNY in Q3 2019, marking a decline of approximately 652%[56] Assets and Liabilities - Total assets increased by 7.74% to CNY 6,466,364,435.04 compared to the end of the previous year[8] - Total liabilities rose to CNY 3,501,467,151.73, up from CNY 2,975,200,571.09 in the previous year[40] - Total assets as of September 30, 2020, amounted to 6.47 billion yuan, an increase from 6.00 billion yuan at the end of 2019[37] - Total liabilities reached CNY 2,975,200,571.09, with current liabilities at CNY 2,721,353,928.81 and non-current liabilities at CNY 253,846,642.28[70] - The company's equity totaled CNY 3,026,505,263.51, with a capital reserve of CNY 2,338,970,867.79 and retained earnings showing a deficit of CNY 163,725,989.12[71] - Total equity amounted to approximately CNY 3.08 billion, with total liabilities and equity reaching about CNY 5.19 billion[76] Cash Flow - The net cash flow from operating activities decreased by 83.76% to CNY 6,608,713.05[8] - The net cash flow from operating activities for Q3 2020 was CNY 8,941,780.68, a decrease of 81.3% compared to CNY 47,900,389.30 in the same period last year[62] - Total cash inflow from operating activities was CNY 3,576,786,548.41, up from CNY 3,414,668,141.96, indicating a growth of 4.8%[62] - Cash outflow for purchasing goods and services was CNY 2,835,603,890.72, an increase of 3.6% from CNY 2,737,624,367.51[62] - The net cash flow from investing activities was CNY -63,614,907.82, showing a slight improvement from CNY -189,777,163.95 in the previous year[63] - Cash inflow from financing activities totaled CNY 1,879,832,855.38, a decrease of 5.2% compared to CNY 1,982,213,824.09[63] - The ending cash and cash equivalents balance was CNY 367,994,235.81, up from CNY 272,826,478.75, reflecting a growth of 35%[63] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,397[11] - The largest shareholder, Changshu Aluminum Foil Factory Co., Ltd., holds 22.31% of the shares[11] Inventory and Prepayments - Inventory increased by 30.37%, amounting to CNY 32,686,000, primarily due to significant increases in the medical clean board sector[19] - Prepaid accounts increased by 295.82%, totaling CNY 85,930,000, due to higher prepayments for subcontracted engineering and equipment procurement[17] - The company reported a decrease in inventory to CNY 569,267,298.76 from CNY 610,202,524.18[40] Financial Expenses and Income - Non-operating income for the year-to-date was CNY 4,047,651.89, after accounting for tax impacts[9] - Investment income increased by 277.8%, an increase of 2.16 million yuan, mainly due to the profit increase from joint ventures[25] - The company recorded investment income of 49,967,726.19 CNY for the year-to-date period, a slight increase from 49,222,339.25 CNY in the previous year, suggesting stable performance in investment activities[57] - The company reported a cash inflow from investment income of CNY 871,472.60, up from CNY 518,917.81, representing a 67.7% increase[63] Research and Development - Research and development expenses for the quarter were CNY 41,463,848.97, up from CNY 34,117,030.64 in the previous period[46] - Research and development expenses for the year-to-date period totaled 65,780,752.83 CNY, a decrease of 10.2% from 73,277,659.42 CNY in the previous year, indicating a potential shift in focus or budget allocation[57] - Research and development expenses for the quarter amounted to CNY 28,541,674.77, an increase from CNY 21,689,426.86 in the previous year, reflecting a growth of approximately 31%[50] Borrowings and Payables - Long-term borrowings increased by 137.98%, an increase of 135 million yuan, primarily due to the increase in long-term bank loans received during the period[22] - Long-term payables increased by 48.14%, an increase of 46.33 million yuan, mainly due to the increase in financing lease business[23] - Short-term borrowings were reported at CNY 1,622,415,030.00, indicating a significant reliance on short-term financing[70] Other Financial Metrics - Other equity instruments decreased by 40.2%, a reduction of 29.25 million yuan, mainly due to the transfer of part of the equity in Youshi Medical[21] - The company recorded other comprehensive income after tax of CNY -2,810,634.18 for the quarter, compared to CNY -714,151.73 in the previous year[48] - The company’s financial expenses for the quarter were CNY 22,668,845.07, up from CNY 17,052,001.78 in the previous year, indicating an increase of approximately 33%[50] - Financial expenses for the year-to-date period were 55,723,989.88 CNY, slightly down from 56,761,654.69 CNY in the previous year, indicating a marginal improvement in financial management[57] Audit and Compliance - The company has not undergone an audit for the third quarter report[77] - The new revenue and leasing standards were implemented starting in 2020, affecting the classification of advance receipts to contract liabilities[76]
常铝股份(002160) - 2020 Q3 - 季度财报